VANCOUVER, British Columbia, Oct. 17, 2017 -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) - (CSE:RQB) is pleased to announce the appointment of five core members of its operational team. The following key individuals will report directly to CEO, George Robinson:
Bill Robinson (no relation) will lead the Company’s efforts in Government/Indigenous Relations and Strategic Partnerships. In this newly created and important role, Mr. Robinson's mandate will be to identify, cultivate and deepen trusting relationships with Federal and Provincial government bodies – Indigenous Peoples or otherwise - as well as to foster mutually beneficial partnerships with select Indigenous Peoples across Canada, specific to the legal production and sale of cannabis.
Benilda Sable will oversee the Company’s unparalleled Quality Assurance and Compliance standards. Benil brings to the Company her expertise from the food, hemp and medical marijuana industries especially with Health Canada, the Government of Canada’s primary front-line inspection agency in Canada’s cannabis sector. Ms. Sable’s experience will be invaluable in ensuring the Company consistently maintains and surpasses the rigorous quality and compliance guidelines set out by Health Canada.
Noel Avila will act as the Company’s direct conduit to newly acquired Alberta Green Biotech. Noel oversees all aspects of the construction, licensing and completion of the 35,500 square foot production facility in Edmonton, Alberta, slated for completion in mid-2018.
Jason Morris is responsible for the Company's Service Delivery and overall Project Management. Jason oversees delivery of security technology, automated horticultural systems and patient management software to the Company’s diverse list of clients. Much of the Company’s research and business development activities fall under Jason's responsibility.
David Cross, CPA, CGA brings 20 years of public practise as a CPA to the Company and will act as the Company’s Chief Financial Officer.
Marla Ritchie brings 25 years’ experience in public markets and will act as the Company’s Corporate Secretary, overseeing all aspects of the Company’s administrative, filing and regulatory requirements pertaining to public company status and trading on the CSE.
“Our organization is fortunate in our ability to field a team of individuals with such an impressive depth of knowledge and experience in each of their respective areas of expertise,” stated George Robinson, RavenQuest’s CEO.
About RavenQuest Biomed Inc.
RavenQuest Biomed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development.
For further details on the Company readers are referred to the Company's web site (www.rqbglobal.com) and its Canadian regulatory filings on SEDAR at www.sedar.com.
On Behalf of the Board of Directors of
RAVENQUEST BIOMED INC.
"George Robinson"
Chief Executive Officer
For further information, please contact:
Mathieu McDonald, Corporate Communications
1-877-282-1586
Neither Canadian Stock Exchange (“CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Stock Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.


Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Instagram Outage Disrupts Thousands of U.S. Users
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 



